Case Studies

George Clinical Renal Scientific Leadership Team Keeps Recruitment on Target in Difficult CKD Study

Despite operational delays, COVID interruptions and Ukraine war outbreak, targets were met.    

Read More

October 28th, 2022

Established Relationships Allow George Clinical to Meet Tight Timelines and Recruitment Challenges in Critical Early Phase Oncology Study

Local knowledge combined with Australia’s favorable conditions keep trial on track and on time. Early phase clinical trials are the first-line research studies in drug development and assess therapies for safety, dosage levels and side effects. These studies form the basis for all further research on therapy, so they must be conducted to very high […]

Read More

July 12th, 2022

George Clinical Brings Robust Retention Strategy and Tactics to Global Rare Renal Disease Studies

We work to keep every patient engaged to the end from risk retention and personal contact with clinical research associates (CRAs) to patient-facing animation in 20 languages. Clinical trials for rare diseases pose specific challenges due to their elusive nature and low patient populations. Research is critical for these often serious and even life-threatening diseases […]

Read More

June 21st, 2022

Global and National Scientific Leadership Helps Move Potential Breakthrough CKD Anemia Treatment Forward

Exceptional kidney and metabolic scientific leadership network provides continuity, communication and cultural expertise in long-term global trial program.   Background The National Institute of Diabetes and Digestive and Kidney Diseases (NIH) estimates that more than one in seven people with kidney disease have anemia, increasing their chance of developing heart problems and strokes. The prevalence […]

Read More

February 3rd, 2022

George Clinical Proves to be Trusted Partner in Global Breast Cancer Trial

Ability to work across cultural, language and timeline barriers sets benchmark and achieves record patient recruitment in China despite pandemic. Situation A Canadian CRO conducting a global and important Phase III early breast cancer trial for a major pharmaceutical company engaged George Clinical as its partner for the Chinese portion of the trial. Globally, the […]

Read More

June 22nd, 2021

George Clinical Conducts First Oncology Immunonutrition Trial in China

Regulatory knowledge, strong communication skills and flexibility to adapt helped move this novel trial forward.    SITUATION  George Clinical was contracted by a globally recognized leader in the field of nutritional science to conduct a prospective, multi-center, randomized, open-label clinical trial to compare the effects of immunonutrition in patients undergoing surgery for gastrointestinal cancer with […]

Read More

April 2nd, 2021

George Clinical’s Scientific Leadership Model Proves Critical to Meeting Difficult Recruitment Targets in Atypical Phase I Study of a New Renal Drug

Having a well-respected clinician as part of the team to communicate the scientific value of the research gave valuable credibility and comfort level to referring physicians. George Clinical was contracted by a mid-size pharmaceutical company to conduct project management and clinical monitoring in a study to evaluate the pharmacokinetics (PK) and safety of a sulfated […]

Read More

November 21st, 2020

George Clinical Meets Challenging Recruitment Targets in Complex Renal Trial

As a strong proponent of trial innovation with experience in quickly adapting to complex and fluid operations, George Clinical was the ideal partner for the SONAR trial. SITUATION George Clinical was contracted by a large biopharmaceutical company to run operations in the APAC region for SONAR, a randomized, multi-country, multicenter, double-blind, parallel, placebo-controlled study of […]

Read More

November 10th, 2020

George Clinical’s Scientific Leadership Achieves Exceptional Integration Between Science and Operations with Unprecedented Low Rates of Loss to Follow Up and Withdrawal of Consent

Landmark CREDENCE renal outcomes trial stopped early based on achievement of pre-specified efficacy criteria.   SITUATION Five million people are predicted to have kidney failure by 2035. This is a global problem causing not only a diminished quality of life for patients, who are at risk for many adverse health outcomes, but also creating great […]

Read More

June 30th, 2020

George Clinical’s Audit Readiness Provides Successful Inspection of Long-Finished Phase III Trial for Chinese Regulatory Agency

With tight turnaround and five years after study completion, George Clinical brings new staff up to inspection standards and trial passes inspection with no significant findings.   SITUATION George Clinical completed a Phase III, randomized, double-blind, double-dummy, parallel group, local registration trial on cancer pain in 2013 and 2014. The trial covered 28 sites and […]

Read More

September 19th, 2020

Add George Clinical to your network